The US Food and Drug Administration is “quietly working hard” to develop a regulatory framework for advanced manufacturing, according to Michael Kopcha, the director of the Office of Pharmaceutical Quality.
Speaking at the Association for Accessible Medicines’ Generics + Biosimilars conference on 8 November, Kopcha said that the program, called the Framework for Advanced Manufacturing Evaluation, or FRAME, would “provide clarity
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?